PerpEquities

Equity · Healthcare

Is CVS Health (CVS) tradable as a perp? Not yet

CVS Health Corp. is a health solutions company providing healthcare services through Health Care Benefits, Health Services, Pharmacy and Consumer Wellness segments.

Not yet listed on any perp exchange

No perpetual-futures venue lists CVS yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
VRTXISRGREGNPFEBSXMRNA

Price chart

Interactive TradingView chart

TradingView symbol NYSE:CVS

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 3h ago
Market cap
$113.4B
Updated 3h ago
Revenue
$415.1B
Trailing 12 months
Revenue growth
+3%
Next fiscal year
Profit margin
+1.2%
P/E
23.2
Peer P/E 18.1
Free cash flow
$11.8B
Trailing 12 months
More metrics
Net income
$4.9B
Trailing 12 months
P/S
0.3
Peer P/E
18.1
Similar listed perps
Revenue estimate
$416.1B
Next fiscal year
Earnings
2026-11-04
Revenue est. $104.5B · Updated 3h ago
Dividend
$0.665
2026-07-23

Fundamental detail

Annual + quarterly
Latest revenue$402.1B
Net margin+0.4%
Free cash flow$7.8B
Net debt$85.1B
2020$268.7B
2021$292.1B
2022$322.5B
2023$357.8B
2024$372.8B
2025$402.1B
PeriodRevenueGrowthNet incomeFCF
2020$268.7B+5%$7.2B$13.4B
2021$292.1B+9%$8B$15.7B
2022$322.5B+10%$4.3B$13.5B
2023$357.8B+11%$8.3B$10.4B
2024$372.8B+4%$4.6B$6.3B
2025$402.1B+8%$1.8B$7.8B
PeriodGross marginOperating marginNet marginROEROA
2020+18.3%+5.2%+2.7%+10.3%+3.1%
2021+17.8%+4.6%+2.7%+10.7%+3.4%
2022+16.9%+2.5%+1.3%+6.0%+1.9%
2023+15.2%+3.8%+2.3%+10.9%+3.3%
2024+13.8%+2.3%+1.2%+6.1%+1.8%
2025+13.8%+2.6%+0.4%+2.4%+0.7%
PeriodCashDebtNet debtCurrent ratio
2020$7.9B$85B$77.2B0.91
2021$9.4B$76B$66.6B0.88
2022$12.9B$70.7B$57.8B0.95
2023$8.2B$79.4B$71.2B0.86
2024$8.6B$82.9B$74.3B0.81
2025$8.5B$93.6B$85.1B0.84
PeriodMarket capEnterprise valueP/SP/E
2020$89.4B$166.6B0.312.5
2021$136.1B$202.7B0.517.2
2022$122.3B$180.1B0.428.3
2023$101.5B$172.7B0.312.2
2024$56.5B$130.9B0.212.3
2025$100.5B$185.6B0.356.7
Q3 2024$95.4B
Q4 2024$97.7B
Q1 2025$94.6B
Q2 2025$98.9B
Q3 2025$102.9B
Q4 2025$105.7B
Q1 2026$100.4B
Q2 2026$106.1B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$95.4B+6%$87M-$1.4B
Q4 2024$97.7B+4%$1.6B$1.1B
Q1 2025$94.6B+7%$1.8B$3.8B
Q2 2025$98.9B+8%$1B$1.3B
Q3 2025$102.9B+8%-$4B$98M
Q4 2025$105.7B+8%$2.9B$2.6B
Q1 2026$100.4B+6%$2.9B$3.4B
Q2 2026$106.1B+7%$3B$5.7B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+13.2%+0.9%+0.1%+0.1%0.0%
Q4 2024+13.2%+2.4%+1.7%+2.2%+0.6%
Q1 2025+15.2%+3.6%+1.9%+2.3%+0.7%
Q2 2025+13.7%+2.4%+1.0%+1.3%+0.4%
Q3 2025+13.4%-3.1%-3.9%-5.5%-1.6%
Q4 2025+12.8%+2.0%+2.8%+3.9%+1.1%
Q1 2026+15.6%+4.7%+2.9%+3.8%+1.2%
Q2 2026+14.8%+4.4%+2.8%+3.8%+1.2%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$6.9B$82.7B$75.8B0.80
Q4 2024$8.6B$82.9B$74.3B0.81
Q1 2025$10.1B$81.2B$71.1B0.82
Q2 2025$11.8B$82.7B$70.9B0.80
Q3 2025$9.2B$81.8B$72.7B0.83
Q4 2025$8.5B$93.6B$85.1B0.84
Q1 2026$9.5B$78.3B$68.8B0.87
Q2 2026$11.3B$76.3B$65B0.87
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$79.2B$155B0.8227.5
Q4 2024$56.5B$130.9B0.68.6
Q1 2025$85.4B$156.6B0.912.0
Q2 2025$87.3B$158.3B0.921.3
Q3 2025$95.7B$168.3B0.9-6.0
Q4 2025$100.8B$185.9B1.08.6
Q1 2026$91.4B$160.2B0.97.8
Q2 2026$132B$197B1.211.1

Refreshed 3h ago

Charts: revenue, profit, cash flow & valuation
Revenue$106.1BQ2 2026
$26.5B$53B$79.6B$106.1BQ3 2023: $89.8BQ4 2023: $93.8BQ1 2024: $88.4BQ2 2024: $91.2BQ3 2024: $95.4BQ4 2024: $97.7BQ1 2025: $94.6BQ2 2025: $98.9BQ3 2025: $102.9BQ4 2025: $105.7BQ1 2026: $100.4BQ2 2026: $106.1BQ3 2023Q2 2026
Net income$3BQ2 2026
-$2.2B-$490M$1.3B$3BQ3 2023: $2.3BQ4 2023: $2BQ1 2024: $1.1BQ2 2024: $1.8BQ3 2024: $87MQ4 2024: $1.6BQ1 2025: $1.8BQ2 2025: $1BQ3 2025: -$4BQ4 2025: $2.9BQ1 2026: $2.9BQ2 2026: $3BQ3 2023Q2 2026
EBITDA$5.9BQ2 2026
$292M$2.1B$4B$5.9BQ3 2023: $4.8BQ4 2023: $4.5BQ1 2024: $3.4BQ2 2024: $4.2BQ3 2024: $2BQ4 2024: $4BQ1 2025: $4.6BQ2 2025: $3.6BQ3 2025: -$1.6BQ4 2025: $3.3BQ1 2026: $5.8BQ2 2026: $5.9BQ3 2023Q2 2026
Free cash flow$5.7BQ2 2026
-$1.2B$1.1B$3.4B$5.7BQ3 2023: $2.2BQ4 2023: -$3.5BQ1 2024: $4.2BQ2 2024: $2.5BQ3 2024: -$1.4BQ4 2024: $1.1BQ1 2025: $3.8BQ2 2025: $1.3BQ3 2025: $98MQ4 2025: $2.6BQ1 2026: $3.4BQ2 2026: $5.7BQ3 2023Q2 2026
EPS$2.31Q2 2026
-$1.77-$0.41$0.95$2.31Q3 2023: $1.75Q4 2023: $1.59Q1 2024: $0.88Q2 2024: $1.41Q3 2024: $0.07Q4 2024: $1.3Q1 2025: $1.41Q2 2025: $0.8Q3 2025: -$3.13Q4 2025: $2.3Q1 2026: $2.3Q2 2026: $2.31Q3 2023Q2 2026
Cash / Debt$11.3BQ2 2026
$23.4B$46.8B$70.2B$93.6BQ3 2023 · Cash: $13BQ3 2023 · Debt: $80.1BQ4 2023 · Cash: $8.2BQ4 2023 · Debt: $79.4BQ1 2024 · Cash: $9.8BQ1 2024 · Debt: $81.8BQ2 2024 · Cash: $12.5BQ2 2024 · Debt: $83.8BQ3 2024 · Cash: $6.9BQ3 2024 · Debt: $82.7BQ4 2024 · Cash: $8.6BQ4 2024 · Debt: $82.9BQ1 2025 · Cash: $10.1BQ1 2025 · Debt: $81.2BQ2 2025 · Cash: $11.8BQ2 2025 · Debt: $82.7BQ3 2025 · Cash: $9.2BQ3 2025 · Debt: $81.8BQ4 2025 · Cash: $8.5BQ4 2025 · Debt: $93.6BQ1 2026 · Cash: $9.5BQ1 2026 · Debt: $78.3BQ2 2026 · Cash: $11.3BQ2 2026 · Debt: $76.3BQ3 2023Q2 2026
CashDebt
Profitability+14.8%Q2 2026
+1.0%+5.8%+10.7%+15.6%Q3 2023 · Gross margin: +15.1%Q4 2023 · Gross margin: +14.8%Q1 2024 · Gross margin: +14.2%Q2 2024 · Gross margin: +14.7%Q3 2024 · Gross margin: +13.2%Q4 2024 · Gross margin: +13.2%Q1 2025 · Gross margin: +15.2%Q2 2025 · Gross margin: +13.7%Q3 2025 · Gross margin: +13.4%Q4 2025 · Gross margin: +12.8%Q1 2026 · Gross margin: +15.6%Q2 2026 · Gross margin: +14.8%Q3 2023 · Operating margin: +4.1%Q4 2023 · Operating margin: +3.6%Q1 2024 · Operating margin: +2.6%Q2 2024 · Operating margin: +3.3%Q3 2024 · Operating margin: +0.9%Q4 2024 · Operating margin: +2.4%Q1 2025 · Operating margin: +3.6%Q2 2025 · Operating margin: +2.4%Q3 2025 · Operating margin: -3.1%Q4 2025 · Operating margin: +2.0%Q1 2026 · Operating margin: +4.7%Q2 2026 · Operating margin: +4.4%Q3 2023 · Net margin: +2.5%Q4 2023 · Net margin: +2.2%Q1 2024 · Net margin: +1.3%Q2 2024 · Net margin: +1.9%Q3 2024 · Net margin: +0.1%Q4 2024 · Net margin: +1.7%Q1 2025 · Net margin: +1.9%Q2 2025 · Net margin: +1.0%Q3 2025 · Net margin: -3.9%Q4 2025 · Net margin: +2.8%Q1 2026 · Net margin: +2.9%Q2 2026 · Net margin: +2.8%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+7.3%Q2 2026
+2.1%+4.2%+6.3%+8.4%Q3 2024: +6.3%Q4 2024: +4.2%Q1 2025: +7.0%Q2 2025: +8.4%Q3 2025: +7.8%Q4 2025: +8.2%Q1 2026: +6.2%Q2 2026: +7.3%Q3 2023Q2 2026
Shares outstanding1.3BQ2 2026
323.3M646.5M969.8M1.3BQ3 2023: 1.3BQ4 2023: 1.3BQ1 2024: 1.3BQ2 2024: 1.3BQ3 2024: 1.3BQ4 2024: 1.3BQ1 2025: 1.3BQ2 2025: 1.3BQ3 2025: 1.3BQ4 2025: 1.3BQ1 2026: 1.3BQ2 2026: 1.3BQ3 2023Q2 2026
Valuation11.1Q2 2026
52.4110.7169.1227.5Q3 2023 · P/E: 9.9Q4 2023 · P/E: 12.4Q1 2024 · P/E: 22.6Q2 2024 · P/E: 10.3Q3 2024 · P/E: 227.5Q4 2024 · P/E: 8.6Q1 2025 · P/E: 12.0Q2 2025 · P/E: 21.3Q3 2025 · P/E: -6.0Q4 2025 · P/E: 8.6Q1 2026 · P/E: 7.8Q2 2026 · P/E: 11.1Q3 2023 · P/S: 1.0Q4 2023 · P/S: 1.1Q1 2024 · P/S: 1.1Q2 2024 · P/S: 0.8Q3 2024 · P/S: 0.8Q4 2024 · P/S: 0.6Q1 2025 · P/S: 0.9Q2 2025 · P/S: 0.9Q3 2025 · P/S: 0.9Q4 2025 · P/S: 1.0Q1 2026 · P/S: 0.9Q2 2026 · P/S: 1.2Q3 2023Q2 2026
P/EP/S
Revenue$402.1B2025
$100.5B$201B$301.6B$402.1B2018: $194.6B2019: $256.8B2020: $268.7B2021: $292.1B2022: $322.5B2023: $357.8B2024: $372.8B2025: $402.1B20182025
Net income$1.8B2025
$1.6B$3.9B$6.1B$8.3B2018: -$594M2019: $6.6B2020: $7.2B2021: $8B2022: $4.3B2023: $8.3B2024: $4.6B2025: $1.8B20182025
EBITDA$9.9B2025
$4.5B$9.1B$13.6B$18.2B2018: $6.7B2019: $16.4B2020: $17.1B2021: $17.5B2022: $12.3B2023: $18.2B2024: $13.7B2025: $9.9B20182025
Free cash flow$7.8B2025
$3.9B$7.9B$11.8B$15.7B2018: $6.8B2019: $10.4B2020: $13.4B2021: $15.7B2022: $13.5B2023: $10.4B2024: $6.3B2025: $7.8B20182025
EPS$1.392025
$1.19$2.95$4.71$6.472018: -$0.572019: $5.082020: $5.462021: $5.952022: $3.262023: $6.472024: $3.662025: $1.3920182025
Cash / Debt$8.5B2025
$23.4B$46.8B$70.2B$93.6B2018 · Cash: $4.1B2018 · Debt: $73.4B2019 · Cash: $5.7B2019 · Debt: $89B2020 · Cash: $7.9B2020 · Debt: $85B2021 · Cash: $9.4B2021 · Debt: $76B2022 · Cash: $12.9B2022 · Debt: $70.7B2023 · Cash: $8.2B2023 · Debt: $79.4B2024 · Cash: $8.6B2024 · Debt: $82.9B2025 · Cash: $8.5B2025 · Debt: $93.6B20182025
CashDebt
Profitability+13.8%2025
+4.3%+9.0%+13.6%+18.3%2018 · Gross margin: +16.2%2019 · Gross margin: +17.7%2020 · Gross margin: +18.3%2021 · Gross margin: +17.8%2022 · Gross margin: +16.9%2023 · Gross margin: +15.2%2024 · Gross margin: +13.8%2025 · Gross margin: +13.8%2018 · Operating margin: +2.1%2019 · Operating margin: +4.7%2020 · Operating margin: +5.2%2021 · Operating margin: +4.6%2022 · Operating margin: +2.5%2023 · Operating margin: +3.8%2024 · Operating margin: +2.3%2025 · Operating margin: +2.6%2018 · Net margin: -0.3%2019 · Net margin: +2.6%2020 · Net margin: +2.7%2021 · Net margin: +2.7%2022 · Net margin: +1.3%2023 · Net margin: +2.3%2024 · Net margin: +1.2%2025 · Net margin: +0.4%20182025
Gross marginOperating marginNet margin
Revenue growth+7.8%2025
+8.0%+16.0%+24.0%+32.0%2019: +32.0%2020: +4.6%2021: +8.7%2022: +10.4%2023: +10.9%2024: +4.2%2025: +7.8%20182025
Shares outstanding1.3B2025
332.3M664.5M996.8M1.3B2018: 1B2019: 1.3B2020: 1.3B2021: 1.3B2022: 1.3B2023: 1.3B2024: 1.3B2025: 1.3B20182025
Valuation56.72025
-72.0-29.113.856.72018 · P/E: -114.92019 · P/E: 14.62020 · P/E: 12.52021 · P/E: 17.22022 · P/E: 28.32023 · P/E: 12.22024 · P/E: 12.32025 · P/E: 56.72018 · P/S: 0.42019 · P/S: 0.42020 · P/S: 0.32021 · P/S: 0.52022 · P/S: 0.42023 · P/S: 0.32024 · P/S: 0.22025 · P/S: 0.320182025
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20268.02$416.1B+3%17
FY 20278.51$429.2B+7%18
FY 20289.71$448.8B+12%13
FY 202910.85$473.6B+18%10
FY 203011.75$491B+22%5
Q1 20272.68$102.7B+2%6

Company events

6
2026-11-04EarningsActual - / Estimate 1.6-
2026-08-05EarningsActual 2.58 / Estimate 1.87Beat
2026-07-23Dividend$0.665-
2026-05-06EarningsActual 2.57 / Estimate 2.21Beat
2026-04-23Dividend$0.665-
2026-02-10EarningsActual 1.09 / Estimate 1Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
VRTX$129B10.229.3+34.9%3ISRG$139B12.644.4+28.4%8REGN$80.8B5.218.7+27.9%6PFE$157.3B2.536.5+6.8%3BSX$64.4B3.117.5+17.5%2MRNA$61.1B27.4-19.3-141.4%21GILD$186.4B6.1-57.7-10.6%7NVO$192B3.810.7+35.3%14

Analyst track record

How the analysts covering CVS have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings143437
Analysts2433
Buy / hold / sell133 / 10 / 0347 / 90 / 0
Upgrades / downgrades / initiations1 / 0 / 112 / 6 / 6
Price targets hit / missed20 / 118 (14%)265 / 148 (64%)
Avg. return after a rating (TipRanks)-9.6%+11.1%
Best / worst call+17.2% / -28.4%+77.0% / -28.4%

After buy calls on this stock: median 21-day move +1.8% vs S&P 500 +0.7% (n = 348)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Stephen BaxterWells Fargo100% hit rate on this stock · 13 targets measuredBuytarget $123Sep 15, 2026
  2. Elizabeth Anderson CFAEvercore ISI90% hit rate on this stock · 21 targets measuredBuytarget $125Aug 6, 2026
  3. Andrew Mok CFABarclays88% hit rate on this stock · 8 targets measuredBuytarget $108Aug 6, 2026

Latest ratings

DateAnalystCallTarget
Sep 15, 2026Stephen BaxterWells FargoBuyMaintained$123article ↗
Sep 15, 2026Allen LutzBank of America SecuritiesBuyMaintained$120article ↗
Sep 15, 2026Stephen BaxterWells FargoBuyMaintained$123
Sep 9, 2026Stephen BaxterWells FargoBuyReiterated$123article ↗
Sep 9, 2026Lance WilkesBernsteinBuyReiterated$106article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$70.00$80.00$90.00$100$110Oct 25 · Buy 20 · Hold 1 · Sell 0Oct 25Nov 25 · Buy 19 · Hold 1 · Sell 0Dec 25 · Buy 20 · Hold 1 · Sell 0Dec 25Jan 26 · Buy 21 · Hold 1 · Sell 0Feb 26 · Buy 21 · Hold 2 · Sell 0Feb 26Mar 26 · Buy 20 · Hold 1 · Sell 0Apr 26 · Buy 19 · Hold 1 · Sell 0Apr 26May 26 · Buy 19 · Hold 1 · Sell 0Jun 26 · Buy 19 · Hold 1 · Sell 0Jun 26Jul 26 · Buy 19 · Hold 2 · Sell 0Aug 26 · Buy 20 · Hold 1 · Sell 0Aug 26Sep 26 · Buy 20 · Hold 1 · Sell 0Oct 25 · avg. target $89.00Nov 25 · avg. target $89.00Dec 25 · avg. target $93.52Jan 26 · avg. target $93.32Feb 26 · avg. target $94.19Mar 26 · avg. target $95.74Apr 26 · avg. target $96.50May 26 · avg. target $102Jun 26 · avg. target $104Jul 26 · avg. target $109Aug 26 · avg. target $113Sep 26 · avg. target $113Oct 25 · month-end close $78.15Nov 25 · month-end close $80.36Dec 25 · month-end close $79.36Jan 26 · month-end close $74.52Feb 26 · month-end close $79.90Mar 26 · month-end close $71.82Apr 26 · month-end close $83.29May 26 · month-end close $90.98Jun 26 · month-end close $103Jul 26 · month-end close $104Aug 26 · month-end close $93.91Sep 26 · month-end close $90.27

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 143 ratings